The first European company called the timing of the production of the Russian vaccine!
The founder and president of the Swiss company Adienne Pharma & Biotech called the assumption that the consent to the production of the Russian Sputnik V vaccine in Europe is part of a propaganda campaign is absurd.
The Swiss Adienne Pharma & Biotech, which was the first in Europe to conclude an agreement on the production of the Russian Sputnik V vaccine, is ready to release the first batches in the third quarter of 2021. The founder and president of the company, Antonio Francesco Di Naro, announced this in an interview with Bloomberg.
“We could start production of commercial batches of Sputnik vaccine at our plant in Lombardy in the third quarter, and then, if the Italian Medicines Agency <…> gives the green light, we will start production of commercial batches,” explained Di Naro. The vaccine will be produced at a plant near Milan.
He noted that his company was selected to produce the vaccine at the initiative of Russia, but rejected the suggestion that this production is part of a propaganda campaign. “This is not a propaganda tool, I don’t know who says that the people of Russia want to propagate for the production of a vaccine in Italy, in fact this is really absurd,” Di Naro said.